We are live on ! Find out more
CKPT

Checkpoint Therapeutics
CKPT

Delisted

CKPT was delisted on the 29th of May, 2025.

Back to rankings

45 hedge funds and large institutions have $13.8M invested in Checkpoint Therapeutics in 2020 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 6

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

62% more capital invested

Capital invested by funds: $8.55M → $13.8M (+$5.27M)

10% more funds holding

Funds holding: 41 → 45 (+4)

0.27% more ownership

Funds ownership: 1.18% → 1.45% (+0.27%)

Holders
45
Holders Change
+4
Holders Change %
+9.76%
% of All Funds
0.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
20
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$1.1M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$216K
3
N
Nuveen
North Carolina
+$182K
4
Northern Trust
Northern Trust
Illinois
+$152K
5
Wells Fargo
Wells Fargo
California
+$137K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$174K
2
Goldman Sachs
Goldman Sachs
New York
-$35K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$30K
4
UBS Group
UBS Group
Switzerland
-$26.6K
5
ECM
ExodusPoint Capital Management
New York
-$21K
Name Holding Trade Value Shares
Change 		Change in
Stake
PPA
26
Parametric Portfolio Associates
Washington
$40K +$36.6K +2,011 New
Morgan Stanley
27
Morgan Stanley
New York
$35K +$18.1K +991 +128%
UBS Group
28
UBS Group
Switzerland
$34K -$26.6K -1,461 -46%
Commonwealth Equity Services
29
Commonwealth Equity Services
Massachusetts
$31K +$29.2K +1,600 New
VF
30
Virtu Financial
New York
$28K +$25.7K +1,411 New
AllianceBernstein
31
AllianceBernstein
Tennessee
$22K +$20.6K +1,130 New
VOYA Investment Management
32
VOYA Investment Management
Georgia
$20K -$16K -877 -46%
Truist Financial
33
Truist Financial
North Carolina
$20K – – –
BNP Paribas Financial Markets
34
BNP Paribas Financial Markets
France
$18.5K +$1.22K +67 +8%
PAM
35
Panagora Asset Management
Massachusetts
$17K – – –
TRCT
36
Tower Research Capital (TRC)
New York
$16K +$14.6K +799 New
Osaic Holdings
37
Osaic Holdings
Arizona
$15K – – –
Legal & General Group
38
Legal & General Group
United Kingdom
$14K +$3.95K +217 +44%
SO
39
STRS Ohio
Ohio
$12K – – –
Bank of America
40
Bank of America
North Carolina
$11K -$174K -9,549 -95%
Citigroup
41
Citigroup
New York
$11K -$182 -10 -2%
PNC Financial Services Group
42
PNC Financial Services Group
Pennsylvania
$8K +$7.43K +408 New
Bank of Montreal
43
Bank of Montreal
Ontario, Canada
$6K +$6.03K +331 New
AIP
44
Ameritas Investment Partners
Nebraska
$4K – – –
MAM
45
Meeder Asset Management
Ohio
$2K – – –
Goldman Sachs
46
Goldman Sachs
New York
– -$35K -2,288 Closed
Susquehanna International Group
47
Susquehanna International Group
Pennsylvania
– -$30K -1,994 Closed
ECM
48
ExodusPoint Capital Management
New York
– -$21K -1,365 Closed
Victory Capital Management
49
Victory Capital Management
Texas
– -$20K -1,358 Closed
Mackenzie Financial
50
Mackenzie Financial
Ontario, Canada
– -$16K -1,077 Closed
1
2

CKPT Hedge Fund Activity: Q2 2020 in Review

45 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q2 2020, worth a combined $13.8M — up 62% from $8.55M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new CKPT positions and 5 closed out — a net gain of 4 holders — while 20 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock, adding an estimated $1.1M. The largest seller was Bank of America, cutting an estimated $174K.

  • 45 institutional investors held Checkpoint Therapeutics (CKPT) as of Q2 2020, up from 41 in Q1 2020.
  • Funds reported $13.8M of Checkpoint Therapeutics stock for Q2 2020, up 62% quarter-over-quarter.
  • 9 funds opened new Checkpoint Therapeutics positions in Q2 2020 and 5 closed out, a net change of +4 holders.
  • The largest Checkpoint Therapeutics buyer in Q2 2020 was BlackRock, an estimated $1.1M added.
  • The largest Checkpoint Therapeutics seller in Q2 2020 was Bank of America, an estimated $174K sold.

Based on aggregated 13F filings for Q2 2020.